Animal Life Sciences - Crunchbase Company Profile & Funding

Q: How much funding has Animal Life Sciences raised to date?

Animal Life Sciences has raised obfuscated.

Overview

Animal Life Sciences

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Animal Life Sciences

CB Rank

166742

Animal Life Sciences focuses on the development and commercialization of treatments for cats and dogs based on human cancer technologies.

Founded

obfuscation

Private

Seed

Houston, Texas, United States

1-10

www.animallifesciences.com/

Biotechnology

Health Care

Pet

Pharmaceutical

Funding Rounds

Seed

OBF

obfuscation

Key People

Terry Tognietti: CEO
Hughes Watler: Chief Financial Officer

Details

Legal Name

Animal Life Sciences, Inc.

Operating Status

Active

Company Type

For Profit

About the Company

Animal Life Sciences operates as a nutritional and pharmaceutical development company. It focuses on licensing, development, and commercialization of safe and effective treatments for cats and dogs based on cutting edge human cancer technologies. The company was founded in 2019 and is headquartered in Houston, Texas.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

WP1066

A drug candidate that inhibits activated STAT3 to induce tumor cell death and stimulate immune response against tumors, targeting glioblastoma and melanoma brain metastases.

WP1122

A prodrug of 2-deoxyglucose designed to improve pharmacokinetics and brain uptake, targeting glycolysis-dependent tumors like pancreatic cancer and glioblastoma.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Animal Life Sciences	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Animal Life Sciences	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Animal Life Sciences	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Animal Life Sciences	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Animal Life Sciences	—	obfuscated obfuscation	—	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Animal Life Sciences	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Animal Life Sciences	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Animal Life Sciences	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Animal Life Sciences	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Animal Life Sciences	—	obfuscated obfuscation	—	Seed